Citation

Jamie A. De Stefano, Richard G. Sleight, George F. Babcock, R. Michael Sramkoski, Peter D. Walzer. Isolation of Pneumocystis carinii cysts by flow cytometry. Parasitology Research. 1992. 78: 179-82.

Citation

Douglas D. Richman. Emergence of mutant HIV reverse transcriptase conferring resistance to AZT. Journal of Enzyme Inhibition and Medicinal Chemistry. 1992. 6: 55-64.

Citation

Karl Kieburtz, Mindell Seidlin, John S. Lambert, Raphael Dolin, Richard C. Reichman, Fred T. Valentine. Extended follow-up of peripheral neuropathy in patients with AIDS and AIDS-related complex treated with dideoxyinosine. Journal of Acquired Immune Deficiency Syndromes. 1992. 5: 60-4.

Citation

Charles S. Rabkin, Margaret W. Hilgartner, K. W. Hedberg, Louis M. Aledort, Angelos Hatzakis, S. Eichinger, M. Elaine Eyster, Gilbert C. White, Craig M. Kessler, Michael M. Lederman. Incidence of lymphomas and other cancers in HIV-infected and HIV-uninfected patients with hemophilia. The Journal of the American Medical Association. 1992. 267: 1090-4.

Citation

Lynne M. Mofenson. The Use of Intravenous Immunoglobulin in Pediatric Human Immunodeficiency Virus Infection. Seminars in Pediatric Infectious Diseases. 1992. 3: 157-166.

Citation

Antonio V. Sison. HIV-1 Infections in Pregnancy and Perinatal Transmission of HIV-1: Current Issues. Pediatric AIDS and HIV Infection: Fetus to Adolescent. 1992. 3

Citation

William E. Dismukes, William G. Powderly, Michael Switow Saag, Gretchen Cloud, Patrick Robinson, Richard D. Meyer, Jeffrey M. Jacobson, John Richard Graybill, Alan M. Sugar, Vincent J. McAuliffe, Stephen E. Follansbee, Carmelita U. Tuazon, John Stern, Judith Feinberg, Richard Hafner. A controlled trial of fluconazole or amphotericin B to prevent relapse of cryptococcal meningitis in patients with the acquired immunodeficiency syndrome. The NIAID AIDS clinical trials group and mycoses study group. New England Journal of Medicine. 1992. 326: 793-8.

Citation

Francesca Aweeka. Pharmacokinetics of concomitantly administered foscarnet and zidovudine for the treatment of human immunodeficiency virus infection (AIDS clinical trials group protocol 053). Antimicrobial Agents and Chemotherapy. 1992. 36: 1773-78.

Citation

Margaret V. Ragni, B. J. Miller, R. Whalen, R. Ptachcinski R. Bleeding tendency, platelet function, and pharmacokinetics of ibuprofen and zidovudine in HIV(+) hemophilic men. American Journal of Hematology. 1992. 40: 176-82.

Citation

Douglas D. Richman. Selection of zidovudine-resistant variants of human immunodeficiency virus by therapy. Current Topics in Microbiology and Immunology. 1992. 176: 131-42.